Mylan Ups Investment In Mapi’s Monthly Glatiramer

Puts Another $20m Into Candidate Undergoing Phase III Trials

 
• By Dave Wallace
  
Calendar
Mapi and Mylan are developing a monthly glatiramer depot formulation • Source: Shutterstock

More from Deals

More from Business